Vernalis to raise £68.5m 10/02/2012
Drug discoverer Vernalis (VER) is to raise £68.5 million as part of a joint venture with US concern Tris Pharma.
Southern Cross Healthcare Group is pinning hopes on its ‘New Horizons’ recovery policy after nearly doubling interim losses to £22.9 million.
Britain’s largest care home operator increased turnover 4.2 per cent to £481 million in the six months to March, which saw the number of homes operated rise by 18 to 752 while average occupancy slid from 88.8 per cent to 86.9 per cent. Fully-listed Southern Cross cut net debt by £7.4 million from September’s year end to £25.7 million in March, though cash fell by £25 million to £6.8 million over the same period.
The company extracted an average weekly fee increase of 3.2 per cent to £553 during the first half-year. It lifted the percentage of its homes in England accorded Two and Three Star ratings from 77 per cent in September to 81 per cent in March.
Chief executive Jamie Buchan warns of a ‘challenging environment’ for Southern Cross, which derives much of its income from local authorities and so confronts a combination of ‘public sector funding restraint and significant disparity in the commissioning practices of local authority budget holders’. That is why he stresses how ‘imperative’ it is for the company to deliver its ‘New Horizons’ programme of improving service, cutting costs and increasing the proportion of care home residents paying for themselves.
Southern Cross argues by spending £6 million on ‘New Horizons’ it can wring £20 million of extra value every year. Buchan proclaims ‘by the end 2011, the company will be a materially better operational business with an improved brand reputation’.
If so, it will not be a moment too soon for investors, who have seen the shares fall from more than £6 in 2007 to 63p today. That is a fraction of the levels at which previous boss Bill Colvin and colleagues sold large chunks before a missed banking re-payment two years ago started the slide and 34p below Growth Company Investor’s sell recommendation in March.
Subscribe today and save 50%. Receive company watch recommendations and extensive company profile tips, released two months ahead of the market.
Advertisement
£100 credit when you open five trades within 60 days – terms apply. Spread Trading is not for everyone please ensure you understand the risks as you may lose more than your initial deposit. Click here for more information.
This unique study analyses the shareholdings of companies listed on AIM, extracting trends including rankings of the value and number of their investments.
Please click here to order your copy of the report or call 0207 250 7056.
Informative features and research on fast-growing companies, small-cap and growth stocks, penny shares, stock market tips and share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.
If you're interested in business tax updates visit our specialist tax guide website.
Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.
Advertisement
Drug discoverer Vernalis (VER) is to raise £68.5 million as part of a joint venture with US concern Tris Pharma.
Magnolia Petroleum (MAGP) has acquired 800 acres in the Mississippi Lime formation in Oklahoma.
Gold explorer Condor Resources (CNR) has reported encouraging results from drilling at its La India project in Nicaragua.
US-focused Nighthawk Energy is launching a $7.5 million program to invest in its Colorado-based Jolly Ranch project.
Africa-focused Tower Resources (TRP) has raised £5.4 million via a placing with a mixture of institutional investors and directors.
Beleaguered travel operator Thomas Cook (TCG) has reported a loss of £91 million its first quarter also announcing the sale of its Indian division.